Mature T-cell leukemias represent rare, but increasingly recognized diseases of
which, compared to their B-cell counterparts, comparatively little is established on
their pathogenesis, diagnosis, and treatment. These leukemic post-thymic T-cell
neoplasms range from the spectrum of chronic, sometimes debilitating disorders such
as T-large granular lymphocytic leukemia (T-LGLL), and related leukemias such as NKLGLL,
to more aggressive malignancies such as T- prolymphocytic leukemia (T-PLL). In
this series, entitled ‘Pathogenesis, Treatment, and Future Directions for Rare T-cell
Leukemias’ we review the current state of the science of these important T-cell neoplasms
to inform on their treatment, diagnosis, and pathophysiology.
| Identifer | oai:union.ndltd.org:DRESDEN/oai:qucosa:de:qucosa:88999 |
| Date | 15 January 2024 |
| Creators | Herling, Marco, Jarjour, Wael, Mishra, Anjali, Brammer, Jonathan E. |
| Publisher | Frontiers Media S.A. |
| Source Sets | Hochschulschriftenserver (HSSS) der SLUB Dresden |
| Language | English |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, doc-type:article, info:eu-repo/semantics/article, doc-type:Text |
| Rights | info:eu-repo/semantics/openAccess |
| Relation | 991527 |
Page generated in 0.0012 seconds